Subbarao Myla, M.D., F.A.C.C., is the Medical Director, Cardiac and Endovascular
Labs and Cardiovascular Research at Jeffrey M. Carlton Heart and Vascular
Institute at Hoag Hospital Newport Beach. Dr. Myla leads the clinical
direction of endovascular therapy and cardiovascular research at Hoag
Heart and Vascular Institute. Under his leadership, Hoag has initiated
more than 25 FDA-regulated clinical trials investigating a variety of
innovative medical devices and procedures, all of which focus on stroke
prevention. Hoag is one of only a handful of medical facilities in the
western United States to participate in these studies.
Dr. Myla also showcases leading-edge techniques to the medical and scientific
community hrough workshops, live demonstration courses and preceptorships.
One of the most extensive projects to-date involves computer-generated
simulation as an instructional tool for physicians. The endeavor is aimed
at accelerating the educational process in endovascular therapy.
Dr. Myla received his medical degree from Guntur Medical College at Nagarjuna
University in India and went on to do his residency training at the University
of British Columbia in Vancouver, Canada followed by residency training
at several renowned New York hospitals. Dr. Myla then completed a cardiology
and interventional cardiology fellowship at the State University of New
York, Down State Coney Island Hospital, and Maimonides Medical Center
in Brooklyn. He is certified by the American Board of Internal Medicine
in interventionalcardiology, critical care medicine, cardiology and internal medicine.
Throughout his career, he has been named a fellow of the American College
of Cardiology (FACC), a fellow of the Society of Cardiovascular Angiography
& Intervention (FSCAI), a member of the International Society of Endovascular
Specialists (ISES) and president of the non-profit Foundation for Endovascular
Education and Research (FEVER). He is the Program Director of the Hoag
Dr. Myla is widely published in professional and peer-reviewed journals
and has authored a number of textbook chapters. He has extensive experience
in clinical trials and carotid interventional trials in the groundbreaking
field of cardiology. Dr. Myla also directs catheterization and endovascular